Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Observing autonomic neuropathies and Ehlers Danlos syndromes over time

Official title: Autonomic Neuropathy and Its Pathophysiology in Autoimmune Autonomic Neuropathies, Postural Orthostatic Tachycardia Syndrome and Ehlers Danlos Syndromes: Peripheral Autonomic Small Fiber Neuropathy or Central Autonomic Failure? Validation of the Malmö POTS Score and a Better Diagnosis of POTS in Patientes With Autnomic Failure (VaGeMAPS-3-step-Diag)

Run by RWTH Aachen University · NCT04310644 · Data updated 2026-11-12

This study is trying to understand how autonomic neuropathies and Ehlers Danlos syndromes change over time in patients compared to healthy individuals.

More Postural Tachycardia Syndrome trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment200 (estimated)
SponsorRWTH Aachen University
Academic / other
Locations1 site (Aachen, North Rhine-Westphalia)
StatusRecruiting
StartedSeptember 15, 2019
Main results expectedSeptember 15, 2028
Study endsSeptember 15, 2029
Registry record updatedFebruary 4, 2025
Trial IDNCT04310644 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 18-80 with autonomic neuropathy, postural orthostatic tachycardia syndrome, hypermobile or classical Ehlers Danlos syndromes, chronic fatigue syndrome, mast cell activation syndrome, or PostCOVID syndrome.

Probably not a fit

Patients with pregnancy, pacemakers, deep brain stimulation, sensory or motor polyneuropathy, or neurodegenerative diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines patients with various autonomic neuropathies and Ehlers Danlos syndromes, comparing them to healthy controls at three different time points: baseline, after 3 months, and after 1.5 years. The goal is to gain insights into the progression of these conditions and their underlying mechanisms, particularly focusing on small fiber neuropathy. Participants will undergo a series of assessments, including laboratory tests, questionnaires, and specialized tests to evaluate their health status and nerve function. The study also aims to validate a German version of the Malmö POTS Score and create a straightforward diagnostic scheme for outpatient care.

Why it matters

Potential benefit: If successful, this study could enhance understanding and management of autonomic neuropathies and Ehlers Danlos syndromes, leading to better patient outcomes.

How similar studies have gone: While this study builds on existing knowledge, the specific combination of conditions and the proposed methodology may offer novel insights into these syndromes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* autonomic neuropathy
* Postural orthostatic tachycardia syndrome
* hypermobile or classical Ehlers Danlos syndromes
* Chronic fatigue syndrome, mast cell activation syndrome and/or PostCOVID
* healty controls
* between 18-80 years
* in patients: diagnosis and clinical testing in our outpatient clinic
* German speaking

Exclusion Criteria:

* pregnancy
* Pacemaker or Deep brain Stimulation
* sensory or motor Polyneuropathy
* neurodegenerative disease

Where it's running

  • University clinic RWTH Aachen
    Aachen, North Rhine-Westphalia, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.